Measures · D05 in 2026 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Question (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 03/2025 – 05/2025
- Better when
- Higher
- Weight
- 2 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- Yes
- In improvement measure
- Yes
- Used in CAI
- No
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2025. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
- Disaster policy
- Higher measure star (2025-2026) for contracts with 25% or more enrolled affected by 2024 disasters and 2025 Los Angeles wildfires. 2025 measure star for contracts exempt from survey fielding because of 2025 Los Angeles Wildfires. Meaningful Measure Person-Centered Care Area:
From the 2026 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2026 star distribution
Not rated: Plan too small to be measured (139); Plan too new to be measured (93); Plan not required to report measure (8); Not enough data available (3)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2026
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H8552 Anthem Blue Cross Life and Health Insurance Company | Elevance Health, Inc. | 1,065 | 79 | 1 | 0 | 9 | 0% |
| S5921 UnitedHealthcare | UnitedHealth Group, Inc. | 2,326,418 | 76 | 1 | 0 | 10 | 0% |
| H6379 Clear Spring Health | Group 1001 | — | 80 | 1 | — | 8 | 0% |
| H3418 UnitedHealthcare | UnitedHealth Group, Inc. | 46,700 | 81 | 1 | −1 | 7 | 0% |
| H5475 Wellcare | Centene Corporation | 18,951 | 82 | 1 | −1 | 6 | 1% |
| H2923 Devoted Health | Devoted Health, Inc. | 17,156 | 82 | 1 | — | 6 | 1% |
| H1215 Wellcare | Centene Corporation | 2,841 | 82 | 1 | −1 | 6 | 1% |
| H5965 Wellcare | Centene Corporation | 1,556 | 82 | 1 | 0 | 6 | 1% |
| H1395 Wellcare | Centene Corporation | 2,553 | 82 | 1 | −1 | 6 | 1% |
| H2117 Wellcare | Centene Corporation | 4,856 | 82 | 1 | −1 | 6 | 1% |
| H0908 Wellcare | Centene Corporation | 8,453 | 82 | 1 | −3 | 6 | 1% |
| H6672 Clear Spring Health | Group 1001 | — | 82 | 1 | — | 6 | 1% |
| H9431 Aetna Medicare | CVS Health Corporation | 666 | 83 | 1 | −1 | 5 | 2% |
| H2737 Health New England Medicare Advantage Plans | Baystate Health, Inc. | 5,052 | 83 | 1 | −1 | 5 | 2% |
| H7389 HealthSpring | Health Care Service Corporation | 0 | 83 | 2 | 0 | 5 | 2% |
| H5970 Humana | Humana Inc. | 87,310 | 83 | 1 | −1 | 5 | 2% |
| H2836 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 2,426 | 83 | 1 | −1 | 5 | 2% |
| H1914 Wellcare | Centene Corporation | 10,826 | 83 | 1 | 0 | 5 | 2% |
| H5439 Wellcare | Centene Corporation | 19,153 | 83 | 1 | 0 | 5 | 2% |
| H6200 Essence Healthcare | Lumeris Group Holdings Corporation | 10,974 | 83 | 1 | −3 | 5 | 2% |
| H5361 AmeriHealth | Independence Health Group, Inc. | 7,765 | 83 | 1 | — | 5 | 2% |
| H9065 AMH Health | Elevance Health, Inc. | 15,024 | 83 | 1 | −1 | 5 | 2% |
| H8211 UnitedHealthcare | UnitedHealth Group, Inc. | 17,243 | 83 | 1 | −1 | 5 | 2% |
| H5435 UnitedHealthcare | UnitedHealth Group, Inc. | 1,420 | 83 | 2 | +1 | 5 | 2% |
| H9387 Wellcare | Centene Corporation | 847 | 83 | 2 | 0 | 5 | 2% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |